PL142759B1 - Process for preparing derivatives of hydantoin - Google Patents
Process for preparing derivatives of hydantoin Download PDFInfo
- Publication number
- PL142759B1 PL142759B1 PL1984247379A PL24737984A PL142759B1 PL 142759 B1 PL142759 B1 PL 142759B1 PL 1984247379 A PL1984247379 A PL 1984247379A PL 24737984 A PL24737984 A PL 24737984A PL 142759 B1 PL142759 B1 PL 142759B1
- Authority
- PL
- Poland
- Prior art keywords
- fluoro
- spiro
- compounds
- dione
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/488,947 US4474967A (en) | 1983-04-27 | 1983-04-27 | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL247379A1 PL247379A1 (en) | 1985-03-26 |
| PL142759B1 true PL142759B1 (en) | 1987-11-30 |
Family
ID=23941785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1984247379A PL142759B1 (en) | 1983-04-27 | 1984-04-24 | Process for preparing derivatives of hydantoin |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4474967A (en, 2012) |
| EP (1) | EP0124327A3 (en, 2012) |
| JP (1) | JPS59205384A (en, 2012) |
| KR (1) | KR860000915B1 (en, 2012) |
| AU (1) | AU542142B2 (en, 2012) |
| CA (1) | CA1226866A (en, 2012) |
| CS (1) | CS250661B2 (en, 2012) |
| DD (1) | DD219772A5 (en, 2012) |
| DK (1) | DK208284A (en, 2012) |
| ES (1) | ES8607312A1 (en, 2012) |
| FI (1) | FI841657L (en, 2012) |
| GR (1) | GR81491B (en, 2012) |
| HU (1) | HU191755B (en, 2012) |
| IL (1) | IL71656A (en, 2012) |
| NO (1) | NO841627L (en, 2012) |
| NZ (1) | NZ207959A (en, 2012) |
| PH (1) | PH22869A (en, 2012) |
| PL (1) | PL142759B1 (en, 2012) |
| PT (1) | PT78476B (en, 2012) |
| SU (1) | SU1240362A3 (en, 2012) |
| YU (1) | YU43358B (en, 2012) |
| ZA (1) | ZA843091B (en, 2012) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3565105D1 (en) * | 1984-08-20 | 1988-10-27 | Pfizer | Process for the production as asymmetric hydantoins |
| US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
| GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| AU2184499A (en) * | 1998-01-30 | 1999-08-16 | R-Tech Ueno, Ltd. | Ophthalmic composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
-
1983
- 1983-04-27 US US06/488,947 patent/US4474967A/en not_active Expired - Fee Related
-
1984
- 1984-04-19 EP EP84302667A patent/EP0124327A3/en not_active Withdrawn
- 1984-04-24 PT PT78476A patent/PT78476B/pt unknown
- 1984-04-24 DD DD84262257A patent/DD219772A5/de not_active IP Right Cessation
- 1984-04-24 PL PL1984247379A patent/PL142759B1/pl unknown
- 1984-04-25 ES ES531873A patent/ES8607312A1/es not_active Expired
- 1984-04-25 NO NO841627A patent/NO841627L/no unknown
- 1984-04-25 CA CA000452774A patent/CA1226866A/en not_active Expired
- 1984-04-25 SU SU843732823A patent/SU1240362A3/ru active
- 1984-04-26 GR GR74517A patent/GR81491B/el unknown
- 1984-04-26 ZA ZA843091A patent/ZA843091B/xx unknown
- 1984-04-26 NZ NZ207959A patent/NZ207959A/en unknown
- 1984-04-26 AU AU27263/84A patent/AU542142B2/en not_active Ceased
- 1984-04-26 HU HU841622A patent/HU191755B/hu not_active IP Right Cessation
- 1984-04-26 IL IL71656A patent/IL71656A/xx not_active IP Right Cessation
- 1984-04-26 KR KR1019840002240A patent/KR860000915B1/ko not_active Expired
- 1984-04-26 FI FI841657A patent/FI841657L/fi not_active Application Discontinuation
- 1984-04-26 CS CS843101A patent/CS250661B2/cs unknown
- 1984-04-26 YU YU741/84A patent/YU43358B/xx unknown
- 1984-04-26 PH PH30605A patent/PH22869A/en unknown
- 1984-04-26 DK DK208284A patent/DK208284A/da not_active Application Discontinuation
- 1984-04-27 JP JP59086040A patent/JPS59205384A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO841627L (no) | 1984-10-29 |
| YU43358B (en) | 1989-06-30 |
| JPS59205384A (ja) | 1984-11-20 |
| NZ207959A (en) | 1987-04-30 |
| PL247379A1 (en) | 1985-03-26 |
| CA1226866A (en) | 1987-09-15 |
| DK208284D0 (da) | 1984-04-26 |
| HUT34197A (en) | 1985-02-28 |
| DK208284A (da) | 1984-10-28 |
| PT78476B (en) | 1986-08-28 |
| CS250661B2 (en) | 1987-05-14 |
| IL71656A0 (en) | 1984-07-31 |
| FI841657A7 (fi) | 1984-10-28 |
| IL71656A (en) | 1987-10-20 |
| PT78476A (en) | 1984-05-01 |
| PH22869A (en) | 1989-01-19 |
| EP0124327A2 (en) | 1984-11-07 |
| EP0124327A3 (en) | 1985-07-31 |
| FI841657A0 (fi) | 1984-04-26 |
| GR81491B (en, 2012) | 1984-12-11 |
| HU191755B (en) | 1987-04-28 |
| ZA843091B (en) | 1985-12-24 |
| KR840008355A (ko) | 1984-12-14 |
| US4474967A (en) | 1984-10-02 |
| FI841657L (fi) | 1984-10-28 |
| ES531873A0 (es) | 1986-06-01 |
| SU1240362A3 (ru) | 1986-06-23 |
| ES8607312A1 (es) | 1986-06-01 |
| KR860000915B1 (ko) | 1986-07-18 |
| AU2726384A (en) | 1984-11-01 |
| AU542142B2 (en) | 1985-02-07 |
| YU74184A (en) | 1986-10-31 |
| DD219772A5 (de) | 1985-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Sarro et al. | 5H-[1, 2, 4] Oxadiazolo [5, 4-d][1, 5] benzothiazepines as anticonvulsant agents in DBA/2 mice | |
| US8389544B2 (en) | Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 | |
| Tan et al. | Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives | |
| PL144294B1 (en) | Method of obtaining novel polycyclic aromatic compounds | |
| CA1284322C (en) | 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4- dihydro-5h-2,3-benzodiazepine and a process for preparing same | |
| Hoffman et al. | Synthesis and LSD-like discriminative stimulus properties in a series of N (6)-alkyl norlysergic acid N, N-diethylamide derivatives | |
| AU2016302755A1 (en) | 5-HT2C receptor agonists and compositions and methods of use | |
| US5476933A (en) | Azepine synthesis via a diels-alder reaction | |
| SK165795A3 (en) | 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives | |
| US4490381A (en) | 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones | |
| EP1726304A1 (en) | Solifenacin-containing composition | |
| Gallos et al. | Expeditious synthesis of aminocyclopentitols from D-ribose via intramolecular nitrone cycloaddition | |
| Hajlaoui et al. | Design, Synthesis and biological evaluation of novel benzopyran derivatives as potential α-amylase inhibitors: An Investigation by Experimental and Computational Studies | |
| PL142759B1 (en) | Process for preparing derivatives of hydantoin | |
| EP0269755A1 (en) | DIBENZ b,e OXEPIN DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME AS ACTIVE INGREDIENT | |
| AU701412B2 (en) | Fused isoindolones | |
| HU195774B (en) | Process for producing new delta-butirolactame derivatives and pharmaceutical compositions containing them as active component | |
| Bertha et al. | (E)-8-Benzylidene Derivatives of 2-Methyl-5-(3-hydroxyphenyl) morphans: Highly Selective Ligands for the. sigma. 2 Receptor Subtype | |
| Watthey et al. | Synthesis and biological properties of thiophene ring analogs of mianserin | |
| Robbins et al. | (Aminoalkyl) carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter | |
| AU615907B2 (en) | Benzofuro (3,2-c) quinoline compounds | |
| De Costa et al. | Novel site-directed affinity ligands for GABA-gated chloride channels: Synthesis, characterization, and molecular modeling of 1-(Isothiocyanatophenyl)-4-tert-butyl-2, 6, 7-trioxabicyclo [2.2. 2] octanes | |
| JPS63135378A (ja) | ブチロラクトン誘導体、その製造方法およびその用途 | |
| Maguire et al. | Absolute configuration of (+)-5-(3-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5, 5-diphenylhydantoin in the dog | |
| EP0168181B1 (en) | Cyclic amides |